YOLFTbeta
00

Sam Chun Dang Pharm. Co. Ltd

000250 · KQ · Healthcare / Pharmaceuticals

179,000.00KRW-3200.00 (-1.76%)

Price History

Full chart

Market Stats

Previous Close182,200.00
Open184,500.00
Day Range177,600.00 – 191,400.00
52-Week Range120,000.00 – 1,233,000.00
Volume78.14K
Market Cap4.14T
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.01%
Beta1.56
50-Day Avg181,658.00
200-Day Avg361,124.00

About

Sam Chun Dang Pharm. Co., Ltd manufactures, distributes, imports, and exports pharmaceuticals in South Korea. It provides ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company was founded in 1943 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryPharmaceuticals
  • CEOMr. Chun In Seok
  • Employees375
  • Headquarters351 Hyoryeong-ro, Seoul, South Korea, 06643, Korea
  • Websitehttps://www.scd.co.kr

Leadership

  • Dae-In YoonChairman and Chief Exec. Officer · b. 1950
  • Mr. Chun In SeokPres & CEO
  • Tae-Eun JangManaging Director and Director · b. 1961
  • Hyung-Gyun JeonManaging Director · b. 1960
  • Dae-Wook KimSr. Managing Director · b. 1955
  • Gwang-Jin LimManaging Director · b. 1956

Financials

Income Statement

Currency: KRW2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue76.65B104.54B118.92B132.06B147.37B160.59B159.96B186.60B166.86B167.27B177.34B192.67B210.92B231.81B
Growth (%)-+36.39%+13.76%+11.05%+11.59%+8.97%-0.39%+16.66%-10.58%+0.25%+6.01%+8.65%+9.47%+9.90%
Cost of Revenue36.63B44.23B49.97B60.05B68.30B75.82B76.76B75.95B72.86B84.20B87.34B95.70B111.26B122.43B
Gross Profit--65.06B72.01B79.07B84.77B83.20B110.66B94.00B83.08B89.99B96.97B99.66B109.38B
Gross Margin--54.70%54.53%53.66%52.78%52.01%59.30%56.33%49.67%50.75%50.33%47.25%47.18%
Operating Expense--46.11B52.35B54.56B61.76B69.94B85.58B88.48B98.86B77.77B88.45B97.08B100.91B
Operating Income5.96B15.88B18.94B19.66B24.51B23.01B13.26B25.07B5.52B-15.78B12.22B8.51B2.58B8.47B
Operating Margin7.77%15.19%15.93%14.89%16.63%14.33%8.29%13.44%3.31%-9.43%6.89%4.42%1.22%3.65%
EBITDA----------19.36B6.46B20.45B24.49B
EBITDA Margin----------10.92%3.35%9.70%10.57%
Net Income1.34B8.72B11.85B11.63B8.71B12.51B8.75B10.45B-965.68M-16.56B5.84B-10.38B-10.92B5.26B
Net Income Margin1.75%8.34%9.96%8.81%5.91%7.79%5.47%5.60%-0.58%-9.90%3.29%-5.39%-5.18%2.27%
R&D1.79B2.26B2.82B4.07B2.95B4.62B8.96B17.92B21.18B32.39B5.47B5.04B7.84B8.53B
R&D as % of Total Revenue2.34%2.16%2.38%3.08%2.00%2.88%5.60%9.61%12.69%19.36%3.09%2.62%3.72%3.68%
Interest Expense00000000638.41M1.90B2.79B2.58B382.54M979.97M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.38%1.13%1.58%1.34%0.18%0.42%

Balance Sheet

Currency: KRW2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets122.08B155.38B172.49B184.26B205.11B230.14B261.16B290.15B317.08B346.00B372.79B408.02B519.77B561.23B
Total Liabilities35.44B36.15B32.81B69.94B79.95B88.80B112.64B132.28B130.45B171.90B199.05B109.56B253.67B197.64B
Total Equity82.14B93.12B105.44B114.32B125.17B141.34B148.52B157.87B186.63B174.09B173.74B220.50B266.11B276.02B
Cash6.24B33.94B33.09B34.55B47.97B61.11B50.61B60.19B58.88B28.12M13.95M40.43B99.58B95.94B
Total Debt-----5.34B9.39B12.01B26.16B-----
Net Debt----------48.48B7.80B--

Cash Flow

Currency: KRW2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.60B15.94B19.55B17.34B17.76B26.09B25.03B30.60B3.25B-7.71B13.28B23.43B21.77B9.79B
Investing Cash Flow-22.65B-13.47B-13.76B-7.23B-9.36B-50.27B-19.34B-19.21B-30.05B-53.94B-8.42B-23.16B-
Financing Cash Flow1.82B--6.99B-1.86B3.22B-3.31B14.81B-2.42B14.66B27.69B13.33B3.39B65.76B-
Capital Expenditure2.86B4.28B8.72B10.97B9.11B3.25B11.55B6.59B8.68B14.88B46.55B21.97B41.30B59.59B
Free Cash Flow---------8.55B-37.01B-33.27B1.45B-19.53B-49.79B
Dividends Paid965.00M965.00M965.00M2.50B2.02B2.06B2.07B2.07B2.07B968.35M968.35M880.82M890.15M4.65B
FCF to OCF---------263.03%480.26%-250.52%6.21%-89.71%-508.45%
Dividend Paid to FCF---------24.18%-2.62%-2.91%60.55%-4.56%-9.34%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Aug 14, 2014Nov 17, 2014Jan 21, 2015May 16, 2015Aug 14, 2015Nov 11, 2015Feb 26, 2016May 12, 2016Aug 11, 2016Nov 11, 2016Mar 24, 2017May 14, 2017Aug 10, 2017Nov 12, 2017Mar 28, 2018May 14, 2018Aug 13, 2018Nov 13, 2018Jan 18, 2019May 14, 2019Aug 13, 2019Nov 12, 2019Jan 19, 2020May 14, 2020Aug 14, 2020Nov 16, 2020Feb 26, 2021May 17, 2021Aug 17, 2021Nov 15, 2021Jan 28, 2022May 16, 2022Aug 16, 2022Nov 14, 2022Feb 10, 2023May 15, 2023Aug 14, 2023Nov 14, 2023Feb 2, 2024May 16, 2024Aug 14, 2024Nov 12, 2024Feb 7, 2025May 15, 2025Aug 12, 2025Nov 12, 2025Dec 31, 2025May 13, 2026Jun 30, 2026
EPS Estimate---------------------------------------------------------------------
EPS Actual81.9317.5669.2057.2361.0762.6369.4093.9385.9073.8339.8387.5233.6583.18-134.90120.65147.14166.3212.00191.34148.94133.41108.96132.58127.14160.25138.00154.53176.81165.48-82.32174.13172.50220.74141.87159.17183.11194.92-73.00144.00124.00341.08-122.4557.6290.89-421.99231.09-192.29-111.37-184.46-262.0780.92-8.57116.5111.4416.13-173.72-535.30215.6550.087.64-47.78-478.0720.56-143.44110.62238.49233.15180.03
Surprise---------------------------------------------------------------------
Timing--------------------Pre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hours-After-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hours-Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap4.14T
Enterprise Value3.93T
Trailing P/E0.00
Forward P/E0.00
Price / Sales15.29
Price / Book13.17
Revenue (TTM)176.52B
Gross Profit (TTM)82.83B
EBITDA17.73B
Profit Margin-0.11%
Operating Margin6.00%
Return on Equity-478.56%
Return on Assets1.84%
Shares Outstanding21.41M
Shares Float13.25M
Beta1.56
Dividend Yield0.01%
Dividend Rate0.00
Payout Ratio7.67%

Dividends

20251×
50.00Dec 29, 2025
20241×
200.00Dec 27, 2024
20201×
50.00Dec 29, 2020
20191×
50.00Dec 27, 2019
20181×
50.00Dec 27, 2018
20171×
50.00Dec 27, 2017
20161×
50.00Dec 28, 2016
20151×
50.00Dec 29, 2015
20141×
75.00Dec 29, 2014
20131×
50.00Dec 27, 2013
20121×
50.00Dec 27, 2012
20111×
50.00Dec 28, 2011
20101×
100.00Dec 29, 2010
20091×
100.00Dec 29, 2009
20081×
50.00Dec 29, 2008
20071×
100.00Dec 27, 2007
20061×
50.00Dec 27, 2006
20051×
100.00Dec 28, 2005
20041×
100.00Dec 29, 2004
20031×
100.00Dec 29, 2003
20021×
100.00Dec 27, 2002
20012×
100.00Dec 27, 2001600.00Jan 2, 2001

Stock Splits

  • Apr 19, 200210:1